Continuous lamivudine treatment in an olt patient despite the appearance of HBV resistant strain: Longitudinal analysis [1]

Transplantation

Volumn 70, Issue 7, 2000, Pages 1111-1112

  Torre, F ^a   Campo, N ^a   Sinelli, N ^a   Brizzolara, R ^a   Andorno, E ^a   Valente, U ^a   Picciotto, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE;

ADULT; CASE REPORT; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REINFECTION; VIRUS REACTIVATION;

EID: 0034667762     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010150-00022     Document Type: Letter

References (4)

1. Histological grading and staging of chronic hepatitis
2. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
3. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group
4. Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment